novel agents in higher-risk mds
Published 3 years ago • 121 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
1:41
novel therapies for high-risk mds
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:32
novel drug targets for mds
-
1:17
exciting novel treatments being developed for mds
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
4:12
novel therapies in low-risk mds
-
3:56
which patients with mf could benefit the most from telomerase inhibitors?
-
3:34
anti-cd47 antibodies & azacitidine for aml and mds
-
22:47
one very annoying thing about heat pumps - time-temperature defrost
-
2:43
novel therapies in the future of mds treatment
-
1:27
ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis
-
1:27
novel targets in low-risk mds
-
1:04
exciting updates in mf: novel targets and agents
-
0:43
mds novel agents & hmas
-
13:31
key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond